Beta-barrel models of soluble amyloid beta oligomers and annular protofibrils

Proteins: Structure, Function and Bioinformatics

Volumn 78, Issue 16, 2010, Pages 3458-3472

  Shafrir, Yinon ^a   Durell, Stewart R ^a   Anishkin, Andriy ^b   Guy, H Robert ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Bldg 142   (United States)

Author keywords

Abeta; Alzheimer's disease; Molecular assemblies; Molecular dynamics; Molecular models; Protein structure; Structure prediction

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; ANNULAR PROTOFIBRIL; GLYCINE; OLIGOMER; PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMINO TERMINAL SEQUENCE; ARTICLE; BETA BARREL; CONTROLLED STUDY; FIBER; HYDROPHILIC CONTACT LENS; HYDROPHOBICITY; MOLECULAR DYNAMICS; MOLECULAR MODEL; PRIORITY JOURNAL; PROTEIN SECONDARY STRUCTURE; PROTEIN STABILITY; PROTEIN STRUCTURE; SIMULATION;

AMINO ACID SEQUENCE; AMYLOID BETA-PEPTIDES; CELL MEMBRANE; HUMANS; MODELS, MOLECULAR; MOLECULAR DYNAMICS SIMULATION; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, QUATERNARY; PROTEIN STRUCTURE, SECONDARY; SOLUBILITY;

EID: 78349244364     PISSN: 08873585     EISSN: 10970134     Source Type: Journal    
DOI: 10.1002/prot.22832     Document Type: Article

References (57)

1. Bharadwaj PR, Dubey AK, Masters CL, Martins RN, Macreadie IG. Abeta aggregation and possible implications in Alzheimer's disease pathogenesis. J Cell Mol Med 2009; 13: 412-421.
2. Hardy JA, Higgins GA. Alzheimer's disease: the amyloid cascade hypothesis. Science 1992; 256: 184-185.
3. Rahimi F, Shanmugam A, Bitan G. Structure-function relationships of pre-fibrillar protein assemblies in Alzheimer's disease and related disorders. Curr Alzheimer Res 2008; 5: 319-341.
4. Arispe N. Architecture of the Alzheimer's A beta P ion channel pore. J Membr Biol 2004; 197: 33-48.
5. Quist A, Doudevski I, Lin H, Azimova R, Ng D, Frangione B, Kagan B, Ghiso J, Lal R. Amyloid ion channels: a common structural link for protein-misfolding disease. Proc Natl Acad Sci U S A 2005; 102: 10427-10432.
6. Podlisny MB, Ostaszewski BL, Squazzo SL, Koo EH, Rydell RE, Teplow DB, Selkoe DJ. Aggregation of secreted amyloid beta-protein into sodium dodecyl sulfate-stable oligomers in cell-culture. J Biol Chem 1995; 270: 9564-9570.
7. Roher AE, Palmer KC, Yurewicz EC, Ball MJ, Greenberg BD. Morphological and biochemical analyses of amyloid plaque core proteins purified from Alzheimer-disease brain-tissue. J Neurochem 1993; 61: 1916-1926.
8. Walsh DM, Tseng BP, Rydel RE, Podlisny MB, Selkoe DJ. The oligomerization of amyloid beta-protein begins intracellularly in cells derived from human brain. Biochemistry 2000; 39: 10831-10839.
9. Gong Y, Chang L, Viola KL, Lacor PN, Lambert MP, Finch CE, Krafft GA, Klein WL. Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss. Proc Natl Acad Sci U S A 2003; 100: 10417-10422.
10. Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, Morgan TE, Rozovsky I, Trommer B, Viola KL, Wals P, Zhang C, Finch CE, Krafft GA, Klein WL. Diffusible, nonfibrillar ligands derived from A beta(1-42) are potent central nervous system neurotoxins. Proc Natl Acad Sci U S A 1998; 95: 6448-6453.
11. Bitan G, Kirkitadze MD, Lomakin A, Vollers SS, Benedek GB, Teplow DB. Amyloid beta-protein (Abeta) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways. Proc Natl Acad Sci U S A 2003; 100: 330-335.
12. Barghorn S, Nimmrich V, Striebinger A, Krantz C, Keller P, Janson B, Bahr M, Schmidt M, Bitner RS, Harlan J, Barlow E, Ebert U, Hillen H. Globular amyloid beta-peptide oligomer-a homogenous and stable neuropathological protein in Alzheimer's disease. J Neurochem 2005; 95: 834-847.
13. Lesne S, Koh MT, Kotilinek L, Kayed R, Glabe CG, Yang A, Gallagher M, Ashe KH. A specific amyloid-beta protein assembly in the brain impairs memory. Nature 2006; 440: 352-357.
14. Westlind-Danielsson A, Arnerup G. Spontaneous in vitro formation of supramolecular beta-amyloid structures, "betaamy balls", by beta-amyloid 1-40 peptide. Biochemistry 2001; 40: 14736-14743.
15. Hoshi M, Sato M, Matsumoto S, Noguchi A, Yasutake K, Yoshida N, Sato K. Spherical aggregates of beta-amyloid (amylospheroid) show high neurotoxicity and activate tau protein kinase I/glycogen synthase kinase-3 beta. Proc Natl Acad Sci U S A 2003; 100: 6370-6375.
16. Kayed R, Pensalfini A, Margol L, Sokolov Y, Sarsoza F, Head E, Hall J, Glabe C. Annular protofibrils are a structurally and functionally distinct type of amyloid oligomer. J Biol Chem 2009; 284: 4230-4237.
17. Lashuel HA, Hartley D, Petre BM, Walz T, Lansbury PTJr. Neurodegenerative disease: amyloid pores from pathogenic mutations. Nature 2002; 418: 291.
18. Lashuel HA, Lansbury PTJr. Are amyloid diseases caused by protein aggregates that mimic bacterial pore-forming toxins? Q Rev Biophys 2006; 39: 167-201.
19. Harper JD, Wong SS, Lieber CM, Lansbury PT. Observation of metastable A beta amyloid protofibrils by atomic force microscopy. Chem Biol 1997; 4: 119-125.
20. Hartley DM, Walsh DM, Ye CPP, Diehl T, Vasquez S, Vassilev PM, Teplow DB, Selkoe DJ. Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons. J Neurosci 1999; 19: 8876-8884.
21. Walsh DM, Lomakin A, Benedek GB, Condron MM, Teplow DB. Amyloid beta-protein fibrillogenesis-detection of a protofibrillar intermediate. J Biol Chem 1997; 272: 22364-22372.
22. Harmeier A, Wozny C, Rost BR, Munter LM, Hua HQ, Georgiev O, Beyermann M, Hildebrand PW, Weise C, Schaffner W, Schmitz D, Multhaup G. Role of amyloid-beta glycine 33 in oligomerization. Toxicity and neuronal plasticity. J Neurosci 2009; 29: 7582-7590.
23. Paravastu AK, Leapman RD, Yau WM, Tycko R. Molecular structural basis for polymorphism in Alzheimer's beta-amyloid fibrils. Proc Natl Acad Sci U S A 2008; 105: 18349-18354.
24. Paravastu AK, Petkova AT, Tycko R. Polymorphic fibril formation by residues 10-40 of the Alzheimer's beta-amyloid peptide. Biophys J 2006; 90: 4618-4629.
25. Tomaselli S, Esposito V, Vangone P, van Nuland NA, Bonvin AM, Guerrini R, Tancredi T, Temussi PA, Picone D. The alpha-to-beta conformational transition of Alzheimer's Abeta-(1-42) peptide in aqueous media is reversible: a step by step conformational analysis suggests the location of beta conformation seeding. Chembiochem 2006; 7: 257-267.
26. Yu LP, Edalji R, Harlan JE, Holzman TF, Lopez AP, Labkovsky B, Hillen H, Barghorn S, Ebert U, Richardson PL, Miesbauer L, Solomon L, Bartley D, Walter K, Johnson RW, Hajduk PJ, Olejniczak ET. Structural characterization of a soluble amyloid beta-peptide oligomer. Biochemistry 2009; 48: 1870-1877.
27. Huang TH, Yang DS, Plaskos NP, Go S, Yip CM, Fraser PE, Chakrabartty A. Structural studies of soluble oligomers of the Alzheimer beta-amyloid peptide. J Mol Biol 2000; 297: 73-87.
28. Cerf E, Sarroukh R, Tamamizu-Kato S, Breydo L, Derclaye S, Dufrene YF, Narayanaswami V, Goormaghtigh E, Ruysschaert JM, Raussens V. Antiparallel beta-sheet: a signature structure of the oligomeric amyloid beta-peptide. Biochem J 2009; 421: 415-423.
29. Kheterpal I, Chen M, Cook KD, Wetzel R. Structural differences in A beta amyloid protofibrils and fibrils mapped by hydrogen exchange-mass spectrometry with on-line proteolytic fragmentation. J Mol Biol 2006; 361: 785-795.
30. Kheterpal I, Lashuel HA, Hartley DM, Wlaz T, Lansbury PT, Wetzel R. A beta protofibrils possess a stable core structure resistant to hydrogen exchange. Biochemistry 2003; 42: 14092-14098.
31. Williams AD, Sega M, Chen ML, Kheterpal I, Geva M, Berthelier V, Kaleta DT, Cook KD, Wetzel R. Structural properties of A beta protofibrils stabilized by a small molecule. Proc Natl Acad Sci U S A 2005; 102: 7115-7120.
32. Zhang A, Qi W, Good TA, Fernandez EJ. Structural differences between A beta(1-40) intermediate oligomers and fibrils elucidated by proteolytic fragmentation and hydrogen/deuterium exchange. Biophys J 2009; 96: 1091-1104.
33. Kirkitadze MD, Condron MM, Teplow DB. Identification and characterization of key kinetic intermediates in amyloid beta-protein fibrillogenesis. J Mol Biol 2001; 312: 1103-1119.
34. Kirkitadze MD, Li H, Condron MM, Zagorski MG, Teplow DB. Formation of an alpha-helix-containing, oligomeric intermediate is an obligatory step in amyloid beta-protein fibrillogenesis. Biophys J 2001; 80: 174A.
35. Petkova AT, Yau WM, Tycko R. Experimental constraints on quaternary structure in Alzheimer's beta-amyloid fibrils. Biochemistry 2006; 45: 498-512.
36. Bernstein SL, Dupuis NF, Lazo ND, Syttenbach T, Condron MM, Bitan G, Teplow DB, Shea J-E, Ruotolo BT, Robinson CV, Bowers MT. Amyloid-beta protein oligomerization and the importance of tetramers and dodecamers in the aetiology of Alzheimer's disease. Nat Chem 2009; 1: 326-331.
37. Masuda Y, Uemura S, Ohashi R, Nakanishi A, Takegoshi K, Shimizu T, Shirasawa T, Irie K. Identification of physiological and toxic conformations in A beta 42 aggregates. Chembiochem 2009; 10: 287-295.
38. Goodsell DS, Olson AJ. Structural symmetry and protein function. Annu Rev Biophys Biomol Struct 2000; 29: 105-153.
39. Jang H, Arce FT, Capone R, Ramachandran S, Lal R, Nussinov R. Misfolded amyloid ion channels present mobile beta-sheet subunits in contrast to conventional ion channels. Biophys J 2009; 97: 3029-3037.
40. Brorsson AC, Bolognesi B, Tartaglia GG, Shammas SL, Favrin G, Watson I, Lomas DA, Chiti F, Vendruscolo M, Dobson CM, Crowther DC, Luheshi LM. Intrinsic determinants of neurotoxic aggregate formation by the amyloid beta peptide. Biophys J 2010; 98: 1677-1684.
41. Chou PY, Fasman GD. Empirical predictions of protein conformation. Annu Rev Biochem 1978; 47: 251-276.
42. Olofsson A, Lindhagen-Persson M, Vestling M, Sauer-Eriksson AE, Ohman A. Quenched hydrogen/deuterium exchange NMR characterization of amyloid-beta peptide aggregates formed in the presence of Cu2+ or Zn2+. FEBS J 2009; 276: 4051-4060.
43. Crescenzi O, Tomaselli S, Guerrini R, Salvadori S, D'Ursi AM, Temussi PA, Picone D. Solution structure of the Alzheimer amyloid beta-peptide (1-42) in an apolar microenvironment. Similarity with a virus fusion domain. Eur J Biochem 2002; 269: 5642-5648.
44. Ponder JW, Richards FM. Tertiary templates for proteins-use of packing criteria in the enumeration of allowed sequences for different structural classes. J Mol Biol 1987; 193: 775-791.
45. Liu WM. Shear numbers of protein beta-barrels: definition refinements and statistics. J Mol Biol 1998; 275: 541-545.
46. Brooks BR, Brooks CLIII, Mackerell ADJr, Nilsson L, Petrella RJ, Roux B, Won Y, Archontis G, Bartels C, Boresch S, Caflisch A, Caves L, Cui Q, Dinner AR, Feig M, Fischer S, Gao J, Hodoscek M, Im W, Kuczera K, Lazaridis T, Ma J, Ovchinnikov V, Paci E, Pastor RW, Post CB, Pu JZ, Schaefer M, Tidor B, Venable RM, Woodcock HL, Wu X, Yang W, York DM, Karplus M. CHARMM: the biomolecular simulation program. J Comput Chem 2009; 30: 1545-1614.
47. Phillips JC, Braun R, Wang W, Gumbart J, Tajkhorshid E, Villa E, Chipot C, Skeel RD, Kale L, Schulten K. Scalable molecular dynamics with NAMD. J Comput Chem 2005; 26: 1781-1802.
48. Humphrey W, Dalke A, Schulten K. VMD: visual molecular dynamics. J Mol Graph 1996; 14: 33-38.
49. Coles M, Bicknell W, Watson AA, Fairlie DP, Craik DJ. Solution structure of amyloid beta-peptide(1-40) in a water-micelle environment. Is the membrane-spanning domain where we think it is? Biochemistry 1998; 37: 11064-11077.
50. Klimov DK, Thirumalai D. Dissecting the assembly of A beta(16-22) amyloid peptides into antiparallel beta sheets. Structure 2003; 11: 295-307.
51. Hung LW, Ciccotosto GD, Giannakis E, Tew DJ, Perez K, Masters CL, Cappai R, Wade JD, Barnham KJ. Amyloid-beta peptide (A beta) neurotoxicity is modulated by the rate of peptide aggregation: A beta dimers and trimers correlate with neurotoxicity. J Neurosci 2008; 28: 11950-11958.
52. Bitan G, Tarus B, Vollers SS, Lashuel HA, Condron MM, Straub JE, Teplow DB. A molecular switch in amyloid assembly: Met(35) and amyloid beta-protein oligomerization. J Am Chem Soc 2003; 125: 15359-15365.
53. Song L, Hobaugh MR, Shustak C, Cheley S, Bayley H, Gouaux JE. Structure of staphylococcal alpha-hemolysin, a heptameric transmembrane pore. Science 1996; 274: 1859-1866.
54. Cowan SW, Schirmer T, Rummel G, Steiert M, Ghosh R, Pauptit RA, Jansonius JN, Rosenbusch JP. Crystal-structures explain functional-properties of 2 Escherichia coli porins. Nature 1992; 358: 727-733.
55. Guy HR, Durell SR. Structural models of lattice, fibril, and membrane-bound assemblies formed by the PrPSc prion protein. In: Proceedings of the Biophysical Society Meeting. 2007. Abstract no. 2667.
56. Naylor R, Hill AF, Barnham KJ. Neurotoxicity in Alzheimer's disease: is covalently crosslinked A beta responsible? Eur Biophys J Biophys Lett 2008; 37: 265-268.
57. Curtain CC, Ali F, Volitakis I, Cherny RA, Norton RS, Beyreuther K, Barrow CJ, Masters CL, Bush AI, Barnham KJ. Alzheimer's disease amyloid-beta binds copper and zinc to generate an allosterically ordered membrane-penetrating structure containing superoxide dismutase-like subunits. J Biol Chem 2001; 276: 20466-20473.